- Trials with a EudraCT protocol (436)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (6)
436 result(s) found for: Kidney Transplantation.
Displaying page 1 of 22.
EudraCT Number: 2007-004284-21 | Sponsor Protocol Number: 987 | Start Date*: 2007-07-06 | |||||||||||
Sponsor Name:POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI | |||||||||||||
Full Title: A prospective randomized study of antibiotic prophylaxis for renal transplantation: short term vs standard treatment | |||||||||||||
Medical condition: antibiotic prophylaxis for renal tranplantation | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-003707-30 | Sponsor Protocol Number: P140501 | Start Date*: 2014-10-23 | |||||||||||
Sponsor Name:ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP) | |||||||||||||
Full Title: | |||||||||||||
Medical condition: | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-019126-13 | Sponsor Protocol Number: CE-US | Start Date*: 2011-03-04 | |||||||||||
Sponsor Name:IST. DI RICERCHE FARMACOLOG. M. NEGRI | |||||||||||||
Full Title: A PILOT, EXPLORATIVE STUDY TO IDENTIFY CONTRAST-ENHANCED ULTRASOUND (CE-US) PATTERNS THAT CHARACTERIZE ACUTE ALLOGRAFT REJECTION AND OTHER CAUSES OF ACUTE ALLOGRAFT DYSFUNCTION IN RENAL TRANSPLANT ... | |||||||||||||
Medical condition: Renal transplant | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-004459-38 | Sponsor Protocol Number: TREACE_2015 | Start Date*: 2016-02-24 | ||||||||||||||||
Sponsor Name:AZIENDA OSPEDALIERA UNIVERSITARIA INTEGRATA VERONA | ||||||||||||||||||
Full Title: EXPLORATIVE STUDY TO IDENTIFY A SPECIFIC TRANSCRIPTOMIC PROFILE FOR PREDICTING THE MAJOR ADVERSE EFFECTS ASSOCIATED WITH CERTICAN (EVEROLIMUS) IN RENAL TRANSPLANT RECIPIENTS: A PHARMACOGENOMIC APPR... | ||||||||||||||||||
Medical condition: kidney transplant | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: IT (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-014997-16 | Sponsor Protocol Number: MPASNP1 | Start Date*: 2010-04-08 | |||||||||||
Sponsor Name:Medizinische Universität Wien, Abteilung für Nephrologie und Dialyse | |||||||||||||
Full Title: Identification of patients with high probability of not or poorly responding to therapy with mycophenolic acid pro-drugs. | |||||||||||||
Medical condition: Patients with a de novo kidney transplantation | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: AT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-002856-17 | Sponsor Protocol Number: SMHREN0501 | Start Date*: 2006-12-28 | |||||||||||
Sponsor Name:Hammersmith Hospital NHS Trust | |||||||||||||
Full Title: A randomised controlled comparison of Campath−Tacrolimus vs IL2R MoAb −Tacrolimus / Mycophenolate as Induction−Maintenance immunosuppression in kidney transplantation. | |||||||||||||
Medical condition: Renal transplant failure and rejection (Live and deceased donor) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-002763-27 | Sponsor Protocol Number: PRINS study | Start Date*: 2007-09-12 | |||||||||||
Sponsor Name:Erasmus MC | |||||||||||||
Full Title: A multi-center, randomized, controlled trial with programmed introduction of Sirolimus-based, Calcineurin inhibitor free immunosuppression in recipients of non-heart-beating donor kidney grafts. | |||||||||||||
Medical condition: Recipients of a renal allograft from a non-heart-beating donor, three months after transplantation. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2005-001496-35 | Sponsor Protocol Number: ISRCTN07963178 | Start Date*: 2006-02-13 | |||||||||||
Sponsor Name:Cambridge University Hospitals NHS Foundation Trust | |||||||||||||
Full Title: A single centre, randomised controlled, open label study of rituximab as induction therapy in kidney transplantation. | |||||||||||||
Medical condition: Renal Transplantation | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-004069-16 | Sponsor Protocol Number: CYP3A4/5RenalTx | Start Date*: 2007-10-19 | |||||||||||
Sponsor Name:Department of Nephrology and Renal Transplantation, KU Leuven | |||||||||||||
Full Title: Hepatic and intestinal CYP3A4/5 activity in renal transplantation. A study assessing in vivo hepatic and intestinal CYP3A4/5 activity at different time-points and in different clinical settings af... | |||||||||||||
Medical condition: Effect of genetic (single nucleotide polymorphisms of genes encoding drug metabolising enzymes and drug transporters) and non-genetic factors (e.g. age, time after transplantation, concommitant me... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2008-004158-33 | Sponsor Protocol Number: CYP3A4/5+PGPinRenalTx | Start Date*: 2008-09-17 | |||||||||||
Sponsor Name:Department of Nephrology and Renal Transplantation, KU Leuven | |||||||||||||
Full Title: CYP3A4/5 and PGP activity in renal transplantation. A study assessing in vivo hepatic and intestinal CYP3A4/5 and PGP activity in kidney transplant recipients and its relationship with genetic and... | |||||||||||||
Medical condition: Effect of genetic (single nucleotide polymorphisms of genes encoding drug metabolising enzymes and drug transporters) and non-genetic factors (e.g. age, time after transplantation, concommitant med... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2008-006072-30 | Sponsor Protocol Number: 0808100 | Start Date*: 2009-01-19 | ||||||||||||||||
Sponsor Name:CHU Saint-Etienne | ||||||||||||||||||
Full Title: Mycophénolate sodic in graded increased doses in the first 3 months of renal transplantation _ Pharmacokinetic descriptive Pilot study | ||||||||||||||||||
Medical condition: renal transplantation | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: FR (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-000771-42 | Sponsor Protocol Number: CRAD001ASE01 | Start Date*: 2007-10-20 | |||||||||||
Sponsor Name:Novartis Pharma Services | |||||||||||||
Full Title: A controlled randomized open-label multicentre study evaluatiing if early conversion to everolimus (Certican) from cyclosporine (Neoral) in de novo renal transplant receipients can improve long-ter... | |||||||||||||
Medical condition: Renal Transplantation | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Completed) DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-013461-25 | Sponsor Protocol Number: UK-02-RG-194_09.0098 | Start Date*: 2010-03-03 | |||||||||||
Sponsor Name:St. George's, University of London | |||||||||||||
Full Title: The influence of CYP3A5 and ABCB1 genotype on the pharmacokinetics of twice daily Tacrolimus and Advagraf | |||||||||||||
Medical condition: Renal transplantation. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-001144-23 | Sponsor Protocol Number: CERL080ADE10 | Start Date*: Information not available in EudraCT | |||||||||||
Sponsor Name:Novartis Pharma GmbH | |||||||||||||
Full Title: Measurement of Patient Reported Gastrointestinal (GI) and Health-related Quality of Life (HRQL) Outcomes in Simultaneous Pancreas-Kidney Transplant Recipients | |||||||||||||
Medical condition: Stable Pancreas-Kidney (SPK) Transplant Recipients | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-000033-19 | Sponsor Protocol Number: 4xmmf | Start Date*: 2007-06-05 | |||||||||||||||||||||
Sponsor Name:UMC Utrecht | |||||||||||||||||||||||
Full Title: An open study to investigate the effect of 4 instead of 2 daily dosing mycophenolate mofetil (MMF) in renal transplant patients on diarrhea | |||||||||||||||||||||||
Medical condition: Diarrhea in renal transplanted patients which use Cellcept® | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: NL (Ongoing) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-008895-15 | Sponsor Protocol Number: HCL/P 2008.537/38 | Start Date*: 2009-02-16 | |||||||||||
Sponsor Name:Hospices Civils de Lyon | |||||||||||||
Full Title: Influence de l'introduction du sirolimus sur la balance inflammatoire chez le transplanté rénal | |||||||||||||
Medical condition: Transplantation rénale | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-014670-17 | Sponsor Protocol Number: CORPAD | Start Date*: 2009-12-07 | |||||||||||
Sponsor Name:H.-Hartziekenhuis Roeselare-Menen vzw | |||||||||||||
Full Title: Controlled study on the Relative Pharmacokinetics of Advagraf versus Prograft in Kidney transplant patients with severe Diarrhoea | |||||||||||||
Medical condition: Renal transplant patients suffering from diarrhea | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-010541-31 | Sponsor Protocol Number: MTOR-METAB | Start Date*: 2010-10-20 | |||||||||||
Sponsor Name:Servicio Nefrología Hospital Universitario de Bellvitge | |||||||||||||
Full Title: Efecto de la inhibición de la diana de rapamicina (mTor) sobre el metabolismo y rendimiento en el ejercicio físico | |||||||||||||
Medical condition: Pacientes trasplantados renales a los que por indicación clínica se les va a realizar un cambio de un fármaco anti-calcineurínico (Ciclosporina o Tacrolimus) a un inhidor de la diana de rapamicina ... | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-005503-13 | Sponsor Protocol Number: 1.0_Custodiol | Start Date*: 2015-02-16 | |||||||||||
Sponsor Name:Essen University Hospital, University of Essen, Klinik für Allgemein-, Viszeral- und Transplantationschirugie | |||||||||||||
Full Title: A prospective randomized single blind monocenter phase II study of organ perfusion with Custodiol-N compared with Custodiol solution in living donor kidney transplantation | |||||||||||||
Medical condition: kidney preservation by Custodiol-N or Custodiol solution before living related kidney transplantation | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-012258-19 | Sponsor Protocol Number: F506-CL-0403 | Start Date*: 2011-03-09 | |||||||||||||||||||||
Sponsor Name:Astellas Pharma Europe Ltd. | |||||||||||||||||||||||
Full Title: A Multicentre, Open-label, Pharmacokinetic Study of Modigraf® (Tacrolimus granules) in de novo Paediatric Allograft Recipients.Estudio Abierto, Multicéntrico, Farmacocinético de Modigraf® (Tacróli... | |||||||||||||||||||||||
Medical condition: De novo allograft transplantation (liver, heart, kidney) in paediatric patients. Pacientes pediátricos que reciben un trasplante de aloinjerto de novo ( hígado, corazón y riñón) | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Newborns, Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: ES (Completed) GB (Completed) DE (Completed) BE (Completed) FR (Ongoing) | |||||||||||||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here
![](img/rss.png)
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
![](img/info.png)